| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3282813 | Clinical Gastroenterology and Hepatology | 2013 | 10 Pages |
Abstract
Based on meta-analysis of observational studies, statin use may be associated with lower risk of esophageal cancer, particularly risk of EAC in patients with BE.
Keywords
EACNSAIDPPIHGDHMG-CoAESCCRCT3-hydroxy-3-methylglutaryl coenzyme AEsophageal adenocarcinomaRandomized controlled trialRelative risknonsteroidal anti-inflammatory drugCholesterol-lowering drugshigh-grade dysplasiaEsophageal squamous cell cancerEsophageal cancerconfidence intervalBarrett's esophagusHMG-CoA reductase inhibitorsProton pump inhibitorodds ratioChemoprevention
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Siddharth Singh, Abha Goyal Singh, Preet Paul Singh, Mohammad Hassan Murad, Prasad G. Iyer,